Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Hardcastle, Sharni Lee ^a   Brenu, Ekua Weba ^a   Johnston, Samantha ^a   Nguyen, Thao ^a   Huth, Teilah ^a   Ramos, Sandra ^a   Staines, Donald ^a   Marshall Gradisnik, Sonya ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Chronic Fatigue Syndrome; Longitudinal; Markers; Natural killer cell; Severity

Indexed keywords

CD16 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; L SELECTIN; NATURAL KILLER CELL RECEPTOR NKG2D; LYMPHOCYTE ANTIGEN RECEPTOR; NCAM1 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DR BELLS DISABILITY SCALE; EFFECTOR CELL; FEMALE; FIBROFATIGUE SCALE; FLOW CYTOMETRY; FUNCTIONAL STATUS ASSESSMENT; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNE DEFICIENCY; INNATE IMMUNITY; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MALE; MEMORY T LYMPHOCYTE; NATURAL KILLER T CELL; PROTEIN EXPRESSION; AGED; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHENOTYPE; YOUNG ADULT;

ADAPTIVE IMMUNITY; ADULT; AGED; ANTIGENS, CD56; CD8-POSITIVE T-LYMPHOCYTES; FATIGUE SYNDROME, CHRONIC; FEMALE; FLOW CYTOMETRY; HUMANS; L-SELECTIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; YOUNG ADULT;

EID: 84941281156     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0653-3     Document Type: Article

References (27)

1. Rathmell JC, Thompson CB. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell. 2002;109(2):S97-107.
2. Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, et al. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2012;10:88.
3. Barker E, Fujimura SF, Fadem MB, Landay AL, Levy JA. Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis. 1994;18(Supplement 1):S136-41.
4. Brenu E, Hardcastle S, Atkinson G, van Driel M, Kreijkamp-Kaspers S, Ashton K et al. Natural killer cells in patients with severe chronic fatigue syndrome. Autoimmun Highlights. 2013;4(3):1-12.
5. Brenu E, Johnston S, Hardcastle S, Huth T, Fuller K, Ramos S, et al. Immune abnormalities in patients meeting new diagnostic criteria for chronic fatigue syndrome/Myalgic Encephalomyelitis. J Mol Biomark Diagn. 2013;4(152.10):4172.
6. Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, et al. Immunological abnormalities as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2011;9:81.
7. Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, et al. Screening NK-, B-and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome. J Transl Med. 2013;11:68.
8. Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. 1990;28(6):1403-10.
9. Patarca R. Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci. 2001;933(1):185-200.
10. Hardcastle S, Brenu E, Johnston S, Nguyen T, Huth T, Kaur M. Analysis of the relationship between immune dysfunction and symptom severity in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). J Clin Cell Immunol. 2014;5(190):2.
11. ter Wolbeek M, van Doornen LJ, Kavelaars A, van de Putte EM, Schedlowski M, Heijnen CJ. Longitudinal analysis of pro-and anti-inflammatory cytokine production in severely fatigued adolescents. Brain Behav Immun. 2007;21(8):1063-74.
12. Hardcastle SL, Brenu EW, Johnston S, Staines D, Marshall-Gradisnik S. Severity scales for use in primary health care to assess Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Health Care Women Int. 2014;1-16 [Epub ahead of print].
13. Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB, et al. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology. 2007;122(1):1-14.
14. Aguinis H, Gottfredson RK, Joo H. Best-practice recommendations for defining, identifying, and handling outliers. Organ Res Methods. 2013;16(2):270-301.
15. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22(11):633-40.
16. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56 bright subset. Blood. 2001;97(10):3146-51.
17. Müller B. Cytokine imbalance in non-immunological chronic disease. Cytokine. 2002;18(6):334-9.
18. Huth T, Brenu E, Nguyen T, Hardcastle S, Johnston S. Characterization of natural killer cell phenotypes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Clin Cell Immunol. 2014;5(223):2.
19. Epling-Burnette PK, Bai F, Painter JS, Rollison DE, Salih HR, Krusch M, et al. Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood. 2007;109(11):4816-24.
20. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Investig. 1995;95(5):2061.
21. Landay A, Lennette E, Jessop C, Levy J. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet. 1991;338(8769):707-12.
22. Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol. 1987;139(10):3306-13.
23. Anane LH, Edwards KM, Burns VE, Zanten JJ, Drayson MT, Bosch JA. Phenotypic characterization of γδ T cells mobilized in response to acute psychological stress. Brain Behav Immun. 2010;24(4):608-14.
24. Farber DL, Yudanin NA, Restifo NP. Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol. 2014;14(1):24-35.
25. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745-63.
26. Morris G, Maes M. A neuro-immune model of myalgic encephalomyelitis/chronic fatigue syndrome. Metab Brain Dis. 2013;28(4):523-40.
27. Poggi A, Carosio R, Fenoglio D, Brenci S, Murdaca G, Setti M, et al. Migration of Vδ1 and Vδ2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. Blood. 2004;103(6):2205-13.